April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Upregulation of complement components and chemokines by interferon gamma (IFN-γ) stimulation of retinal pigment epithelium (RPE) in vitro
Author Affiliations & Notes
  • Sijia Cao
    Ophthal & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Aikun Wang
    Ophthal & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Jing Z Cui
    Ophthal & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Joanne A Matsubara
    Ophthal & Visual Sciences, University of British Columbia, Vancouver, BC, Canada
  • Footnotes
    Commercial Relationships Sijia Cao, None; Aikun Wang, None; Jing Cui, None; Joanne Matsubara, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3436. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sijia Cao, Aikun Wang, Jing Z Cui, Joanne A Matsubara; Upregulation of complement components and chemokines by interferon gamma (IFN-γ) stimulation of retinal pigment epithelium (RPE) in vitro. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3436.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Drusen are hallmark deposits of age-related macular degeneration (AMD) and are hypothesized to mediate RPE dysfunction. Our previous studies demonstrated that two drusen components, advanced glycation end products and amyloid-beta, upregulated IFN-γ and IFN-γ signaling pathways in RPE cells in vitro. IFN-γ is a soluble cytokine associated with innate and adaptive immunity, and recent studies point towards an emerging relationship between IFN-γ and mechanisms underlying the pathogenesis of AMD. Here we focus on understanding effects of IFN-γ on RPE gene expression.

Methods: Primary fetal RPE cells were exposed to 12.5 or 25ng/ml IFN-γ in serum-free DMEM culture medium for 12h and 24h, respectively. The IFN-γ induced cytotoxicity was evaluated by lactate dehydrogenase (LDH) assay. Cells were lysed to collect mRNA and the RNA expression of complement components, inflammatory cytokines and chemokines were analyzed by quantitative PCR (q-PCR).

Results: Cell death was unchanged for both 12.5 and 25ng/ml IFN-γ at 24h compared to untreated cells. IFN-γ treatment upregulated complement factor H (CFH), complement factor B (CFB) and C3 (fold change > 2, p < 0.05), but did not affect the expression level of complement regulators CD46/55/59, complement factor I (CFI), complement factor D (CFD) or C5. IFN-γ also upregulated CX3CL1 (fractalkine) (>10) and MCP-1 (>2) in RPE cells at 12h and 24h (p < 0.01). IFN-γ at the tested concentration did not change the expression level of IL-1β, IL-18, IL-6, IL-8, TNF-α, IL-1ra and VEGF-A.

Conclusions: IFN-γ at the concentration tested does not have an adverse effect on survival of RPE cells, but it can affect the gene expression of RPE related to pro-inflammatory mediators. Our data demonstrated that several complement components are upregulated by IFN-γ. In addition, IFN-γ stimulation promoted chemokine upregulation, especially CX3CL1 from RPE cells. The significant upregulation of fractalkine, CX3CL1, a membrane-bound chemokine, may play an important role in the early AMD by promoting immune cell chemotaxis in outer retina in response to drusen components. Therefore, targeting the release of cleaved CX3CL1 from RPE origin may be an important strategy to suppress immune cell chemotaxis into outer retina.

Keywords: 412 age-related macular degeneration • 701 retinal pigment epithelium • 557 inflammation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×